LOADING
Comparing Merck & Company (MRK) and Intel Corporation (INTC) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | INTC |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $298.8B | $241.2B |
| P/E Ratio | 16.6 | -- |
| Forward P/E | 23.5 | 88.5 |
| PEG Ratio | 3.68 | 0.50 |
| EPS | $7.27 | $-0.06 |
| Revenue Growth (YoY) | 5.0% | -4.1% |
| Profit Margin | 28.1% | -0.5% |
| Return on Equity | 36.9% | 0.0% |
| Dividend Yield | 2.69% | -- |
| Beta | 0.26 | 1.38 |
| 52-Week High | $124.22 | $54.60 |
| 52-Week Low | $70.74 | $17.66 |
| Volume | -- | -- |
Merck & Company is the larger company by market capitalization. Merck & Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.